UCLA Jonsson Comprehensive Cancer Center — Los Angeles, California

UCLA Jonsson Comprehensive Cancer Center is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Jonsson Comprehensive Cancer Center has participated in 274 clinical trials with 136 currently active.

Therapeutic areas: Adult Solid Neoplasm, Childhood Solid Neoplasm, Metastatic Neoplasm.

Sponsors: Jonsson Comprehensive Cancer Center, National Cancer Institute (NCI), NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Jonsson Comprehensive Cancer Center?

UCLA Jonsson Comprehensive Cancer Center has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Jonsson Comprehensive Cancer Center conducted?

UCLA Jonsson Comprehensive Cancer Center has 274 clinical trials on record, with 136 currently active. Their work covers Adult Solid Neoplasm, Childhood Solid Neoplasm, Metastatic Neoplasm.

Is UCLA Jonsson Comprehensive Cancer Center accredited by Crixeo Clinical Trials?

UCLA Jonsson Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Jonsson Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.